Literature DB >> 30187113

Focus on acute kidney injury 2017.

Miet Schetz1, John Prowle2,3.   

Abstract

Entities:  

Mesh:

Year:  2018        PMID: 30187113     DOI: 10.1007/s00134-018-5357-8

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  15 in total

Review 1.  Contrast-associated acute kidney injury in the critically ill: systematic review and Bayesian meta-analysis.

Authors:  Stephan Ehrmann; Andrew Quartin; Brian P Hobbs; Vincent Robert-Edan; Cynthia Cely; Cynthia Bell; Genevieve Lyons; Tai Pham; Roland Schein; Yimin Geng; Karim Lakhal; Chaan S Ng
Journal:  Intensive Care Med       Date:  2017-02-14       Impact factor: 17.440

2.  Validating benefit of biomarker-directed therapy for acute kidney injury: can you have your cake and eat it?

Authors:  J R Prowle; M Schetz
Journal:  Intensive Care Med       Date:  2017-02-16       Impact factor: 17.440

3.  Have biomarkers failed in acute kidney injury? We are not sure.

Authors:  John R Prowle; Mitchell H Rosner
Journal:  Intensive Care Med       Date:  2017-04-24       Impact factor: 17.440

4.  Does this critically ill patient with oliguria need more fluids, a vasopressor, or neither?

Authors:  Frédérique Schortgen; Miet Schetz
Journal:  Intensive Care Med       Date:  2017-03-14       Impact factor: 17.440

5.  How to improve the care of patients with acute kidney injury.

Authors:  Rinaldo Bellomo; Suvi T Vaara; John A Kellum
Journal:  Intensive Care Med       Date:  2017-06-09       Impact factor: 17.440

6.  Effects of restricting perioperative use of intravenous chloride on kidney injury in patients undergoing cardiac surgery: the LICRA pragmatic controlled clinical trial.

Authors:  David McIlroy; Deirdre Murphy; Jessica Kasza; Dhiraj Bhatia; Lisa Wutzlhofer; Silvana Marasco
Journal:  Intensive Care Med       Date:  2017-03-25       Impact factor: 17.440

Review 7.  Current state of the art for renal replacement therapy in critically ill patients with acute kidney injury.

Authors:  Sean M Bagshaw; Michael Darmon; Marlies Ostermann; Fredric O Finkelstein; Ron Wald; Ashita J Tolwani; Stuart L Goldstein; David J Gattas; Shigehiko Uchino; Eric A Hoste; Stephane Gaudry
Journal:  Intensive Care Med       Date:  2017-03-13       Impact factor: 17.440

8.  AKIpredictor, an online prognostic calculator for acute kidney injury in adult critically ill patients: development, validation and comparison to serum neutrophil gelatinase-associated lipocalin.

Authors:  Marine Flechet; Fabian Güiza; Miet Schetz; Pieter Wouters; Ilse Vanhorebeek; Inge Derese; Jan Gunst; Isabel Spriet; Michaël Casaer; Greet Van den Berghe; Geert Meyfroidt
Journal:  Intensive Care Med       Date:  2017-01-27       Impact factor: 17.440

9.  Balanced Crystalloids versus Saline in Critically Ill Adults.

Authors:  Matthew W Semler; Wesley H Self; Jonathan P Wanderer; Jesse M Ehrenfeld; Li Wang; Daniel W Byrne; Joanna L Stollings; Avinash B Kumar; Christopher G Hughes; Antonio Hernandez; Oscar D Guillamondegui; Addison K May; Liza Weavind; Jonathan D Casey; Edward D Siew; Andrew D Shaw; Gordon R Bernard; Todd W Rice
Journal:  N Engl J Med       Date:  2018-02-27       Impact factor: 91.245

10.  Prevention of cardiac surgery-associated AKI by implementing the KDIGO guidelines in high risk patients identified by biomarkers: the PrevAKI randomized controlled trial.

Authors:  Melanie Meersch; Christoph Schmidt; Andreas Hoffmeier; Hugo Van Aken; Carola Wempe; Joachim Gerss; Alexander Zarbock
Journal:  Intensive Care Med       Date:  2017-01-21       Impact factor: 17.440

View more
  3 in total

1.  Admission serum sodium and potassium levels predict survival among critically ill patients with acute kidney injury: a cohort study.

Authors:  Xu-Ping Gao; Chen-Fei Zheng; Min-Qi Liao; Hong He; Yan-Hua Liu; Chun-Xia Jing; Fang-Fang Zeng; Qing-Shan Chen
Journal:  BMC Nephrol       Date:  2019-08-08       Impact factor: 2.388

2.  A risk prediction model for acute kidney injury in patients with pulmonary tuberculosis during anti-tuberculosis treatment.

Authors:  Zhi Xiang Du; Fang Qun Chang; Zi Jian Wang; Da Ming Zhou; Yang Li; Jiang Hua Yang
Journal:  Ren Fail       Date:  2022-12       Impact factor: 2.606

3.  An Inhibitor of DRP1 (Mdivi-1) Alleviates LPS-Induced Septic AKI by Inhibiting NLRP3 Inflammasome Activation.

Authors:  Ruijin Liu; Si-Cong Wang; Ming Li; Xiao-Hui Ma; Xiao-Nan Jia; Yue Bu; Lei Sun; Kai-Jiang Yu
Journal:  Biomed Res Int       Date:  2020-07-11       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.